GET THE APP

Biosensors and Bioelectronics Enable Salivary Cancer Diagnosis
..

Biosensors & Bioelectronics

ISSN: 2155-6210

Open Access

Perspective - (2022) Volume 13, Issue 2

Biosensors and Bioelectronics Enable Salivary Cancer Diagnosis

Erin Persil*
*Correspondence: Erin Persil, Department of Organic Chemistry, University of Murcia, Spain, Email:
Department of Organic Chemistry, University of Murcia, Spain

Received: 19-Feb-2022, Manuscript No. jbsbe-22-58509; Editor assigned: 21-Feb-2022, Pre QC No. P-58509; Reviewed: 05-Mar-2022, QC No. Q-58509; Revised: 10-Mar-2022, Manuscript No. R-58509; Published: 17-Mar-2022 , DOI: 10.4172/2155-6210.22.13.315
Citation: Persil, Erin. "Biosensors and Bioelectronics Enable Salivary Cancer Diagnosis." J Biosens Bioelectron 13 (2022): 315. DOI: 10.4172/2155-6210.22.13.315
Copyright: © 2022 Persil E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

In the realm of cancer, substantial technological improvements have been made in acquiring predictive, diagnostic, and prognostic information throughout the previous century. Every year, around 1.7 million Americans are diagnosed with cancer, with 600,000 people dying as a result. Many of the existing diagnostic procedures for malignant malignancies, on the other hand, are ineffective [1]. Low sensitivity/specificity, long tests, and expensive equipment have all been identified as drawbacks. As well as invasive procedures Two studies, for example, indicated that 40-year-old women who get an annual.

If you get a mammography every ten years, you have a 23% risk of getting a false positive for breast cancer. Ovarian cancer; even with the requisite regular check-ups, the diagnosis rate of ovarian malignancies is low are not good. As a result, several researches have been conducted to address the aforementioned difficulties. Many research organisations are now studying the assessment and efficacy of saliva for local and systemic malignancies after realising the potential of salivary cancer diagnostics in the late 1990s [2]. The utilisation of saliva as a handy technique of obtaining reliable cancer information is discussed here. Saliva has been dubbed "the mirror of the human body" because to its diffusive qualities.

About the Study

Capillary diffusion permits a tiny fraction of serum indicators to move through different media and phospholipid bilayer interstitial locations. Because ionic molecules cannot diffuse through the phospholipid bilayer, they must pass via junction gaps, which are known as hyper-filtration. If the biomarker is not lipid soluble, it passes in lower concentrations via active transport or ultrafiltration. Saliva is useful since it may be obtained in a non-invasive manner.

There are three major salivary glands and 600 to 1000 smaller glands in the mouth. Whole saliva and cell free saliva are the two types of saliva that can be extracted and used to obtain diagnostic information. 90% of WS is secreted by the parotid, submandibular, and sublingual glands, which include 99.5% and % proteins, microbiomes, and other compounds [3]. The glands are usually stimulated with gum or citric acid to extract WS. CFS, on the other hand, is taken directly from the glands, although it does so through an intrusive procedure.

The macromolecules are useful for cancer diagnostics since they are continually created and controlled; for example, uric acid dysregulation has a significant link to oral malignancies. Salivary cancer biomarkers, as well as detection techniques, biosensors, and bioelectronics, are all being investigated. On the basis of type, stage, and sensitivity/specificity, cancer biomarkers are evaluated [4]. Prognostic biomarkers are used to predict whether a tumour is benign or malignant, whereas diagnostic biomarkers reveal the progression of disease [5].

Conclusion

Predictive biomarkers, on the other hand, show the derived benefit from a given therapeutic treatment. For the diagnosis of salivary cancer, standard approaches and various types of electrochemical biosystems are used. For the identification of salivary cancer biomarkers, standard approaches and several types of electrochemical biosystems were used. Because saliva has lower concentrations of biomarkers than serum in blood, the study of salivary biomarkers necessitates nanoscale instruments that are very sensitive and selective.

References

  1. Berney, H., J. West, E. Haefele, J. Alderman, and W. Lane, et al. "A DNA diagnostic biosensor: development, characterisation and performance." Sensors and Actuators B: Chemical 68 (2000):100-108.
  2. Google Scholar, Crossref

     
  3. Vercoutere, Wenonah, and Mark Akeson. "Biosensors for DNA sequence detection." Curr Opin Chem Biol 6 (2002): 816-822.
  4. Google Scholar, Crossref

  5. Bougadi, Eleni TH, and Despina P. Kalogianni. "Based DNA biosensor for food authenticity testing." Food Chem 322(2020): 126758.
  6. Google Scholar, Crossref

  7. Mikkelsen and Susan R. "Electrochecmical biosensors for DNA sequence detection." Electroanalysis 8 (1996): 15-19.
  8. Google Scholar, Crossref

  9. Kavita, V. J. J. B. B. S. "DNA biosensors: A review." J Bioeng Biomed Sci 7 (2017): 222.
  10. Google Scholar, Crossref

Google Scholar citation report
Citations: 1751

Biosensors & Bioelectronics received 1751 citations as per Google Scholar report

Biosensors & Bioelectronics peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward